1 pixel 1 empty pixel
Government Officials at Teva Canada

Government tour of Teva Canada’s Stouffville manufacturing facility showcases pharmaceutical capabilities and underscores economic value to Canada

A Centre of Pharmaceutical Excellence - The Stouffville manufacturing facility, one of North America’s largest, produces generic medicines in tablet and capsule dosage forms spanning a wide range of therapies including pain management, cardiovascular diseases, and mental health. The facility provides end-to-end manufacturing of medicines, from dispensing the raw materials to the production of the finished dosage format.
Categorized in: Advanced Manufacturing, Business, Life Sciences & Health Technology Posted on: Last updated on: Written by:
Government Officials at Teva Canada

Municipal government officials from The Regional Municipality of York, Chairman and CEO, Wayne Emmerson, Chief of Staff, Lina Bigioni and Director of Economic Strategy, Jonathan Wheatle, and from the Town of Whitchurch-Stouffville, Mayor Iain Lovatt, recently toured Teva Canada Limited’s (Teva Canada) solid dose pharmaceutical manufacturing facility in Whitchurch-Stouffville, Ontario.

“The Teva Canada team was honoured to host our esteemed guests at the Stouffville facility, a Centre of Excellence within Teva Pharmaceuticals’ global supply chain,” said Michael Sine, General Manager, Teva Canada. “We were proud to highlight our contribution to the Canadian economy as well as this manufacturing facility’s capabilities.”

Full Article: tevacanada.com